FAD-I, a Fusobacterium nucleatum cell wall-associated diacylated lipoprotein that mediates human beta defensin 2 induction through Toll-like receptor-1/2 (TLR-1/2) and TLR-2/6

Infection and Immunity

Volumn 84, Issue 5, 2016, Pages 1446-1456

  Bhattacharyya, Sanghamitra ^a,c   Ghosh, Santosh K ^a   Shokeen, Bhumika ^b   Eapan, Betty ^a   Lux, Renate ^b   Kiselar, Janna ^c   Nithianantham, Stanley ^a,d   Young, Andrew ^c   Pandiyan, Pushpa ^a   McCormick, Thomas S ^a,c   Weinberg, Aaron ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 2; CYSTEINE; DIACYLGLYCEROL; FUSOBACTERIUM ASSOCIATED DEFENSIN INDUCER; LIPOPROTEIN; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 6; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA DEFENSIN; DEFB4A PROTEIN, HUMAN; FAD-I PROTEIN, FUSOBACTERIUM NUCLEATUM; MESSENGER RNA; RECOMBINANT PROTEIN; TLR2 PROTEIN, HUMAN; TLR6 PROTEIN, HUMAN;

ARTICLE; BACTERIAL STRAIN; CELL LYSATE; ESCHERICHIA COLI; FUSOBACTERIUM NUCLEATUM; GENE ACTIVATION; GENE ACTIVITY; GENE EXPRESSION; GENE INTERACTION; GENETIC TRANSCRIPTION; HETEROLOGOUS EXPRESSION; HOST PATHOGEN INTERACTION; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; TANDEM MASS SPECTROMETRY; AMINO ACID SUBSTITUTION; BIOSYNTHESIS; CELL CULTURE; EPITHELIUM CELL; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PROTEIN MULTIMERIZATION; PROTEIN SYNTHESIS; TRANSCRIPTION INITIATION;

AMINO ACID SUBSTITUTION; ANTI-INFECTIVE AGENTS; BACTERIAL PROTEINS; BETA-DEFENSINS; CELLS, CULTURED; CYSTEINE; DIGLYCERIDES; EPITHELIAL CELLS; ESCHERICHIA COLI; FUSOBACTERIUM NUCLEATUM; HUMANS; PROTEIN BIOSYNTHESIS; PROTEIN MULTIMERIZATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT PROTEINS; RNA, MESSENGER; TOLL-LIKE RECEPTOR 1; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 6; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 84965102001     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01311-15     Document Type: Article

References (58)

1. Gupta S, Ghosh SK, Scott ME, Bainbridge B, Jiang B, Lamont RJ, McCormick TS, Weinberg A. 2010. Fusobacterium nucleatumassociated beta-defensin inducer (FAD-I): identification, isolation, and functional evaluation. J Biol Chem 285:36523-36531. http://dx.doi.org/10.1074/jbc.M110.133140.
2. Gomes PDS, Fernandes MH. 2010. Defensins in the oral cavity: distribution and biological role. J Oral Pathol Med 39:1-9. http://dx.doi.org/10.1111/j.1600-0714.2009.00832.x.
3. Gursoy UK, Könönen E. 2012. Understanding the roles of gingival betadefensins. J Oral Microbiol 2012:4. http://dx.doi.org/10.3402/jom.v4i0.15127.
4. Hancock RE, Sahl HG. 2006. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24:1551-1557. http://dx.doi.org/10.1038/nbt1267.
5. Krisanaprakornkit S, Kimball JR, Weinberg A, Darveau RP, Bainbridge BW, Dale BA. 2000. Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect Immun 68:2907-2915. http://dx.doi.org/10.1128/IAI.68.5.2907-2915.2000.
6. Dale BA, Krisanaprakornkit S. 2001. Defensin antimicrobial peptides in the oral cavity. J Oral Pathol Med 30:321-327. http://dx.doi.org/10.1034/j.1600-0714.2001.300601.x.
7. Ji S, Shin JE, Kim YS, Oh JE, Min BM, Choi Y. 2009. Toll-like receptor 2 and NALP2 mediate induction of human beta-defensins by fusobacterium nucleatum in gingival epithelial cells. Infect Immun 77:1044-1052. http://dx.doi.org/10.1128/IAI.00449-08.
8. Dommisch H, Reinartz M, Backhaus T, Deschner J, Chung W, Jepsen S. 2012. Antimicrobial responses of primary gingival cells to Porphyromonas gingivalis. J Clin Periodontol 39:913-922. http://dx.doi.org/10.1111/j.1600-051X.2012.01933.x.
9. Ghosh SK, Gerken TA, Schneider KM, Feng Z, McCormick TS, Weinberg A. 2007. Quantification of human beta-defensin-2 and-3 in body fluids: application for studies of innate immunity. Clin Chem 53:757-765. http://dx.doi.org/10.1373/clinchem.2006.081430.
10. Ghosh SK, Gupta S, Jiang B, Weinberg A. 2011. Fusobacterium nucleatum and human beta-defensins modulate the release of antimicrobial chemokine CCL20/macrophage inflammatory protein 3α. Infect Immun 79:4578-4587. http://dx.doi.org/10.1128/IAI.05586-11.
11. Jin G, Kawsar HI, Hirsch SA, Zeng C, Jia X, Feng Z, Ghosh SK, Zheng QY, Zhou A, McIntyre TM, Weinberg A. 2010. An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis. PLoS One 5:e10993. http://dx.doi.org/10.1371/journal.pone.0010993.
12. Kawsar HI, Weinberg A, Hirsch SA, Venizelos A, Howell S, Jiang B, Jin G. 2009. Overexpression of human beta-defensin-3 in oral dysplasia: potential role in macrophage trafficking. Oral Oncol 45:696-702. http://dx.doi.org/10.1016/j.oraloncology.2008.10.016.
13. Doss M, White MR, Tecle T, Hartshorn KL. 2010. Human defensins and LL-37 in mucosal immunity. J Leukoc Biol 87:79-92. http://dx.doi.org/10.1189/jlb.0609382.
14. Feng Z, Jia X, Adams MD, Ghosh SK, Bonomo RA, Weinberg A. 2014. Epithelial innate immune response to Acinetobacter baumannii challenge. Infect Immun 82:4458-4465. http://dx.doi.org/10.1128/IAI.01897-14.
15. Ganz T. 2003. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3:710-720. http://dx.doi.org/10.1038/nri1180.
16. Kimball JR, Nittayananta W, Klausner M, Chung WO, Dale BA. 2006. Antimicrobial barrier of an in vitro oral epithelial model. Arch Oral Biol 51:775-783. http://dx.doi.org/10.1016/j.archoralbio.2006.05.007.
17. Yin L, Dale BA. 2007. Activation of protective responses in oral epithelial cells by Fusobacterium nucleatum and human beta-defensin-2. J Med Microbiol 56:976-987. http://dx.doi.org/10.1099/jmm.0.47198-0.
18. Pazgier M, Prahl A, Hoover DM, Lubkowski J. 2007. Studies of the biological properties of human beta-defensin 1. J Biol Chem 282:1819-1829. http://dx.doi.org/10.1074/jbc.M607210200.
19. Harder J, Gläser R, Schröder JM. 2007. Human antimicrobial proteins: effectors of innate immunity. J Endotoxin Res 13:317-338. http://dx.doi.org/10.1177/0968051907088275.
20. Weinberg A, Jin G, Sieg S, McCormick TS. 2012. The yin and yang of human beta-defensins in health and disease. Front Immunol 3:294. http://dx.doi.org/10.3389/fimmu.2012.00294.
21. Kolenbrander PE, Palmer RJ, Jr, Periasamy S, Jakubovics NS. 2010. Oral multispecies biofilm development and the key role of cell-cell distance. Nat Rev Microbiol 8:471-480. http://dx.doi.org/10.1038/nrmicro2381.
22. Kolenbrander PE. 2011. Multispecies communities: interspecies interactions influence growth on saliva as sole nutritional source. Int J Oral Sci 3:49-54. http://dx.doi.org/10.4248/IJOS11025.
23. Krisanaprakornkit S, Kimball JR, Dale BA. 2002. Regulation of human beta-defensin-2 in gingival epithelial cells: the involvement of mitogenactivated protein kinase pathways, but not the NF-kappaB transcription factor family. J Immunol 168:316-324. http://dx.doi.org/10.4049/jimmunol.168.1.316.
24. Oda D, Watson E. 1990. Human oral epithelial cell culture. I. Improved conditions for reproducible culture in serum-free medium. In Vitro Cell Dev Biol 26:589-595.
25. Haake SK, Yoder SC, Attarian G, Podkaminer K. 2000. Native plasmids of Fusobacterium nucleatum: characterization and use in development of genetic systems. J Bacteriol 182:1176-1180. http://dx.doi.org/10.1128/JB.182.4.1176-1180.2000.
26. Shevchuk NA, Bryksin AV, Nusinovich YA, Cabello FC, Sutherland M, Ladisch S. 2004. Construction of long DNA molecules using long PCRbased fusion of several fragments simultaneously. Nucleic Acids Res 32: e19. http://dx.doi.org/10.1093/nar/gnh014.
27. Kaplan A, Kaplan CW, He X, McHardy IH, Shi W, Lux R. 2014. Characterization of aid1, a novel gene involved in Fusobacterium nucleatum interspecies interactions. Microb Ecol 68:379-387. http://dx.doi.org/10.1007/s00248-014-0400-y.
28. Kennell W, Holt SC. 1990. Comparative studies of the outer membranes of Bacteroides gingivalis, strains ATCC 33277, W50, W83, 381. Oral Microbiol Immunol 5:121-130. http://dx.doi.org/10.1111/j.1399-302X.1990.tb00409.x.
29. Rozen S, Skaletsky H. 2000. Primer3 on theWWWfor general users and for biologist programmers. Methods Mol Biol 132:365-386.
30. de Castro E, Sigrist CJ, Gattiker A, Bulliard V, Langendijk-Genevaux PS, Gasteiger E, Bairoch A, Hulo N. 2006. ScanProsite: detection of PROSITE signature matches and ProRule-associated functional and structural residues in proteins. Nucleic Acids Res 34:W362-W365. http://dx.doi.org/10.1093/nar/gkl124.
31. Emr SD, Silhavy TJ. 1983. Importance of secondary structure in the signal sequence for protein secretion. Proc Natl Acad Sci U S A 80:4599-4603. http://dx.doi.org/10.1073/pnas.80.15.4599.
32. Singh P, Sharma L, Kulothungan SR, Adkar BV, Prajapati RS, Ali PS, Krishnan B, Varadarajan R. 2013. Effect of signal peptide on stability and folding of Escherichia coli thioredoxin. PLoS One 8:e63442. http://dx.doi.org/10.1371/journal.pone.0063442.
33. Roy A, Kucukural A, Zhang Y. 2010. I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 5:725-738. http://dx.doi.org/10.1038/nprot.2010.5.
34. Zhang Y. 2008. I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 9:40. http://dx.doi.org/10.1186/1471-2105-9-40.
35. Mascioni A, Bentley BE, Camarda R, Dilts DA, Fink P, Gusarova V, Hoiseth SK, Jacob J, Lin SL, Malakian K, McNeil LK, Mininni T, Moy F, Murphy E, Novikova E, Sigethy S, Wen Y, Zlotnick GW, Tsao DH. 2009. Structural basis for the immunogenic properties of the meningococcal vaccine candidate LP2086. J Biol Chem 284:8738-8746. http://dx.doi.org/10.1074/jbc.M808831200.
36. Kovacs-Simon A, Titball RW, Michell SL. 2011. Lipoproteins of bacterial pathogens. Infect Immun 79:548-561. http://dx.doi.org/10.1128/IAI.00682-10.
37. Tokuda H. 2009. Biogenesis of outer membranes in Gram-negative bacteria. Biosci Biotechnol Biochem 73:465-473. http://dx.doi.org/10.1271/bbb.80778.
38. Kapatral V, Anderson I, Ivanova N, Reznik G, Los T, Lykidis A, Bhattacharyya A, Bartman A, Gardner W, Grechkin G, Zhu L, Vasieva O, Chu L, Kogan Y, Chaga O, Goltsman E, Bernal A, Larsen N, D'Souza M, Walunas T, Pusch G, Haselkorn R, Fonstein M, Kyrpides N, Overbeek R. 2002. Genome sequence and analysis of the oral bacterium Fusobacterium nucleatum strain ATCC 25586. J Bacteriol 184:2005-2018. http://dx.doi.org/10.1128/JB.184.7.2005-2018.2002.
39. Tschumi A, Nai C, Auchli Y, Hunziker P, Gehrig P, Keller P, Grau T, Sander P. 2009. Identification of apolipoprotein N-acyltransferase (Lnt) in mycobacteria. J Biol Chem 284:27146-27156. http://dx.doi.org/10.1074/jbc.M109.022715.
40. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K, Akira S. 1999. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11:443-451. http://dx.doi.org/10.1016/S1074-7613(00)80119-3.
41. Hashimoto M, Tawaratsumida K, Kariya H, Aoyama K, Tamura T, Suda Y. 2006. Lipoprotein is a predominant Toll-like receptor 2 ligand in Staphylococcus aureus cell wall components. Int Immunol 18:355-362.
42. Hashimoto M, Tawaratsumida K, Kariya H, Kiyohara A, Suda Y, Krikae F, Kirikae T, Götz F. 2006. Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. J Immunol 177:3162-3169. http://dx.doi.org/10.4049/jimmunol.177.5.3162.
43. Kurokawa K, Lee H, Roh KB, Asanuma M, Kim YS, Nakayama H, Shiratsuchi A, Choi Y, Takeuchi O, Kang HJ, Dohmae N, Nakanishi Y, Akira S, Sekimizu K, Lee BL. 2009. The triacylated ATP binding cluster transporter substrate-binding lipoprotein of Staphylococcus aureus functions as a native ligand for Toll-like receptor 2. J Biol Chem 284:8406-8411. http://dx.doi.org/10.1074/jbc.M809618200.
44. Nakayama H, Kurokawa K, Lee BL. 2012. Lipoproteins in bacteria: structures and biosynthetic pathways. FEBS J 279:4247-4268. http://dx.doi.org/10.1111/febs.12041.
45. Takeda K, Takeuchi O, Akira S. 2002. Recognition of lipopeptides by Toll-like receptors. J Endotoxin Res 8:459-463. http://dx.doi.org/10.1177/09680519020080060101.
46. Takeuchi O, Akira S. 2010. Pattern recognition receptors and inflammation. Cell 140:805-820. http://dx.doi.org/10.1016/j.cell.2010.01.022.
47. Takeuchi O, Kawai T, Mühlradt PF, Morr M, Radolf JD, Zychlinsky A, Takeda K, Akira S. 2001. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol 13:933-940. http://dx.doi.org/10.1093/intimm/13.7.933.
48. Buwitt-Beckmann U, Heine H, Wiesmüller KH, Jung G, Brock R, Akira S, Ulmer AJ. 2005. Toll-like receptor 6-independent signaling by diacylated lipopeptides. Eur J Immunol 35:282-289. http://dx.doi.org/10.1002/eji.200424955.
49. Buwitt-Beckmann U, Heine H, Wiesmüller KH, Jung G, Brock R, Akira S, Ulmer AJ. 2006. TLR1-and TLR6-independent recognition of bacterial lipopeptides. J Biol Chem 281:9049-9057. http://dx.doi.org/10.1074/jbc.M512525200.
50. Kinane DF, Shiba H, Stathopoulou PG, Zhao H, Lappin DF, Singh A, Eskan MA, Beckers S, Waigel S, Alpert B, Knudsen TB. 2006. Gingival epithelial cells heterozygous for Toll-like receptor. Genes Immun 7:190-200. http://dx.doi.org/10.1038/sj.gene.6364282.
51. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DY. 2002. Endogenous antimicrobial peptides and skin infections in atopic dermatitis.NEngl J Med 347:1151-1160. http://dx.doi.org/10.1056/NEJMoa021481.
52. Starner TD, Agerberth B, Gudmundsson GH, McCray PB, Jr. 2005. Expression and activity of beta-defensins and LL-37 in the developing human lung. J Immunol 174:1608-1615. http://dx.doi.org/10.4049/jimmunol.174.3.1608.
53. O'Neil DA, Porter EM, Elewaut D, Anderson GM, Eckmann L, Ganz T, Kagnoff MF. 1999. Expression and regulation of the human betadefensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol 163: 6718-6724.
54. Wehkamp J, Fellermann K, Herrlinger KR, Baxmann S, Schmidt K, Schwind B, Duchrow M, Wohlschläger C, Feller AC, Stange EF. 2002. Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease. Eur J Gastroenterol Hepatol 14:745-752. http://dx.doi.org/10.1097/00042737-200207000-00006.
55. Diamond G, Beckloff N, Weinberg A, Kisich KO. 2009. The roles of antimicrobial peptides in innate host defense. Curr Pharm Des 15:2377-2392. http://dx.doi.org/10.2174/138161209788682325.
56. Zasloff M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-395. http://dx.doi.org/10.1038/415389a.
57. Ge Y, MacDonald DL, Holroyd KJ, Thornsberry C, Wexler H, Zasloff M. 1999. In vitro antibacterial properties of pexiganan, an analog of magainin. Antimicrob Agents Chemother 43:782-788.
58. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A, Lopez R, Thompson JD, Gibson TJ, Higgins DG. 2007. Clustal W and Clustal X version 2.0. Bioinformatics 23:2947-2948. http://dx.doi.org/10.1093/bioinformatics/btm404.